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article under the CC BY-NC-ND licenseAbstract Use of the da Vinci surgical robotic system has expanded to numerous upper and
lower urinary tract procedures. We describe our surgical technique and perioperative outcome
of robotic distal ureterectomywith psoas hitch and ureteroneocystostomy for distal ureteral pa-
thologies. Eight patients with amedian age of 69.5 years old underwent robotic distal ureterect-
omy with psoas hitch and ureteroneocystostomy between April 2009 and August 2014. The
entirety of all cases was performed robotically by a single surgeon at a tertiary academic med-
ical center. Median operative time was 285 min (range: 210e360 min), estimated blood loss was
50 mL (range: 50e75 mL) and median length of hospital stay was 2.5 days (range: 1e6 days).
There was one post-operative complication, a readmission for dehydration (Clavien I). It sug-
gests that robotic distal ureterectomy with psoas hitch and ureteroneocystostomy is a safe
and effective minimally invasive alternative for patients with distal ureteral pathology.
ª 2015 Editorial Office of Asian Journal of Urology. Production and hosting by Elsevier
(Singapore) Pte Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Laparoscopic ureterectomy was first described by Chad-
hoke and colleagues in 1993 [1]. More recently robotic
surgery has expanded to address lower urinary tract pro-
cedures including ureteral pathologies following thedu (L.-M. Su).
f Chinese Urological Associa-
.04.017
sian Journal of Urology. Productio
(http://creativecommons.org/lisuccess of robotic prostatectomy and partial nephrectomy
[2e5]. Herein, we present our institutional experience and
description of robotic distal ureterectomy with psoas hitch
and ureteroneocystostomy for distal ureteral pathology.
2. Patients and methods
Following institutional review board approval, a retro-
spective chart review was performed at a large tertiary
care academic institution to identify patients who under-
went robotic distal ureterectomy for the treatment ofn and hosting by Elsevier (Singapore) Pte Ltd. This is an open access
censes/by-nc-nd/4.0/).
124 J. Pugh et al.distal ureteral pathology including urothelial carcinoma or
benign stricture disease from April 2009 to August 2014. All
patients underwent appropriate diagnostic imaging and
evaluation including history and physical examination,
cystoscopy, routine serum chemistries and cross sectional
imaging with CT or MRI. Patients were offered all reason-
able options depending on their underlying pathology to
include surveillance, endoscopic, open, laparoscopic and
robotic management with their attendant risks and bene-
fits. The entirety of all procedures was performed roboti-
cally by a single surgeon at a tertiary academic medical
center.Figure 1 Mobilized ureter with diseased segment exposed
following division of ipsilateral medial umbilical ligament.
Figure 2 In cases of ureteral carcinoma, the ureter is clipped
immediately distal to the tumor to help prevent distal
dissemination of tumor cells.3. Technique
3.1. Preoperative preparation
The patient is given one bottle of magnesium citrate the
day prior to surgery and diet is limited to clears. A broad-
spectrum antibiotic such as cefazolin is administered
intravenously within 30 min of incision. Sequential
compression stockings are placed on the lower extremities.
After the induction of anesthesia, an orogastric tube is
placed.
3.2. Patient positioning and port placement
Patient positioning is similar to that for robotic prostatec-
tomy. The patient is positioned supine and the arms are
tucked to the sides. The patient legs are adducted and
slightly flexed. The patient is secured to the operating
table using 3 inch cloth tape over the chest. An 18 Fr ure-
thral catheter is placed at the beginning of the case.
A Veress needles is used to create pneumoperitoneum.
A 12-mm trocar is placed at or slightly above the level of
the umbilicus. The patient is then placed in steep Trende-
lenburg. Two 8-mm trocars are placed lateral to the rectus
muscle on either side near the anterior axillary line and just
below the level of the umbilicus. An additional 8-mm trocar
is placed two to three finger breadths above the iliac crest
on the left to accommodate the fourth robotic arm. For the
assistant, a 12-mm trocar is placed in the right lower
quadrant.
3.3. Exposure of ureter
Maryland bipolar forceps and curved monopolar scissors are
used for the left and robotic arms respectively. The fourth
arm contains a Prograsp forceps. A 30-degree down lens
was used throughout the dissection. The posterior perito-
neum is incised at the level of the iliac vessels above the
ureter of interest. Once identified, the ureter is dissected
distally towards the posterior bladder to the level of the
ureterovesical junction. Division of the ipsilateral vas def-
erens in a male patient or suspensory/broad, round and
infundibulopelvic ligaments in a female patient may aid in
identification and exposure of the distal ureter. Impor-
tantly, necessary division of the ipsilateral medial umbilical
ligament allows for the bladder to be rotated medially, thus
improving exposure and visualization of the ureterovesicaljunction (Fig. 1). Additionally, the superior and sometimes
inferior vesical arteries require division to fully mobilize
the ipsilateral bladder. When the surgery is being per-
formed for urothelial cancer of the ureter, the ureter can
be clipped early in the dissection thus containing the can-
cer and reducing the risk of tumor seeding the lower urinary
tract (Fig. 2).
3.4. Excision of diseased segment
When performing a distal ureterectomy for ureteral cancer,
intravesical mitomycin C (40 mg) is instilled 1 h prior to
cystotomy and excision of the ureteral orifice. In addition,
the bladder is thoroughly rinsed with 300e400 mL of sterile
saline to ensure complete clearance of mitomycin C from
the bladder. The diseased segment of the ureter and a
formal bladder cuff is excised in an extravesical approach
with visual confirmation of complete excision of the ipsi-
lateral ureteral orifice. The disease segment is immediately
entrapped within a specimen sack for later extraction. The
cystotomy is then closed with a two-layered sutured repair
using a 3-0 polyglactin suture (Fig. 3).
Figure 3 With the ureterovesical junction adequately
exposed, a formal bladder cuff with visual confirmation of
complete excision of the ipsilateral ureteral orifice is achieved
through an extravesical approach and the bladder is closed in
two layers.
Figure 5 Ipsilateral dome of the bladder is sutured to the
psoas minor tendon and muscle with 2-0 PDS suture taking
great care to avoid injury to the nearby genitofemoral nerve.
Robotic distal ureterectomy 1253.5. Mobilization of the bladder
In preparation for psoas hitch reconstruction, the bladder is
further dissected from the anterior abdominal wall by
dividing the urachus and contralateral medial umbilical
ligament (Fig. 4). In our experience dividing the contra-
lateral pedicle has not been necessary. However, care must
be taken to leave adequate blood supply if the ipsilateral
pedicle is taken during mobilization of the bladder to
remove the distal ureter and bladder cuff for cancer cases.
3.6. Psoas hitch
When performing a psoas hitch, the psoas minor tendon is
identified immediately superior and lateral to the ipsilat-
eral common iliac vessels. A 2-0 PDS suture is used to fix the
ipsilateral dome of the bladder to the psoas muscle and
tendon. Care must be taken to avoid injury to the nearby
genitofemoral nerve (Fig. 5).Figure 4 The urachus and contralateral medial umbilical
ligament are divided to optimize mobilization of the bladder in
efforts to achieve a tension-free ureteroneocystostomy.3.7. Ureteroneocystostomy
An approximately 1.5 cm incision is made in the bladder
dome along the anterolateral surface in a location where
the remnant ureter can be implanted in a tension free
manner. The ureter is spatulated posteriorly and an
extravesical mucosa to mucosa anastomosis is performed
using 4-0 polyglactin suture in an interrupted fashion
(Fig. 6). Prior to closing the anterior portion of the anas-
tomosis, a ureteral stent is placed in a retrograde fashion
with the aid of a guide wire (Fig. 7). The anastomosis is
tested by filling the bladder with 150e200 mL of normal
saline. A closed suction drain is then placed (Fig. 8). The
specimen is extracted and all port sites are closed.
3.8. Post-operative care
Most patients can be safely discharged by postoperative
day 2. The pelvic drain can be removed prior to discharge as
long as outputs are low. The urethral catheter is removedFigure 6 Ureteroneocystostomy is completed by spatulating
the ureter posteriorly, creating a 1.5-cm cystotomy and re-
approximating the mucosal surfaces using 4-0 polyglactin
sutures.
Figure 7 A double pigtail ureteral stent is placed in a
retrograde fashion before completion of the anterior
anastomosis.
Figure 8 Final view of completed robotic psoas hitch and
ureteroneocystostomy with placement of a pelvic drain.








1 84/M Left robotic distal
ureterectomy
285 50
2 53/M Left robotic distal
ureterectomy
210 50
3 77/F Left robotic distal
ureterectomy
285 75
4 46/F Left robotic distal
ureterectomy
210 50
5 62/F Left robotic distal
ureterectomy
210 50
6 84/M Right robotic distal
ureterectomy
300 75
7 91/F Right robotic distal
ureterectomy
300 75
8 48/F Left robotic distal
ureterectomy
330 50
OR, operative time; EBL, estimated blood loss; LOS, length of hospita
126 J. Pugh et al.7e10 days after surgery. A cystogram can be performed prior
to removal of the urethral catheter. In this series no patient
required a cystogram because all patients had awater closure
intraoperatively and low drain output postoperatively. The
ureteral stent is removed 4 weeks after surgery.
4. Results
Table 1 lists patient demographics and perioperative data
for the robotic distal ureterectomy group. The median age
was 69.5 years (46e91). The median operative time was
285 min (range: 210e330 min), estimated blood loss was
50 mL (range: 50e75 mL), median length of stay was 2.5
days (1e6), and there was one complication in this group
involving readmission for failure to thrive and dehydration
(Grade II). Four of the patients underwent surgery for
ureteral strictures secondary to stone disease with pathol-
ogy demonstrating fibrosis. The remaining four patients
underwent surgery for upper tract urothelial carcinoma.
Pathology was carcinoma in situ (CIS) in one patient, pT1 in
one patient, pT2 in one patient and pT3 in one patient.
Lymph node dissection was performed in all four patients
and they were N0 collectively. All surgical margins were
negative. The remaining four patients were done for stric-
ture disease/fibrosis.
5. Discussion
With the recent expansion of robotic surgery in the field of
urology, the robotic platform has being applied to treat
many genitourinary disease processes in both the upper and
lower urinary tract. For appropriately selected patients,
robotic distal ureterectomy is a viable treatment option.
The robotic platform has some distinct advantages over
both open and laparoscopic approaches. The articulating
wrist of the robot facilitates easier intracorporeal suturing
for the psoas hitch and the anastomosis as compared to
conventional laparoscopy. The 10 magnification allows forL) LOS (day) Complications Pathology Follow-up
(month)
3 None CIS 24
1 None Fibrosis N/A
3 None pT3N0 30
2 None Fibrosis N/A




6 None pT2N0 12
2 None Fibrosis N/A
l stay; CIS, carcinoma in situ.
Robotic distal ureterectomy 127better visualization and more precise dissection. As
compared to open surgery, the same standards of surgical
repair can be achieved in a minimally invasive fashion with
less incisional morbidity and postoperative convalescence.
6. Conclusion
The technique of robotic distal ureterectomy with psoas
hitch and ureteroneocystostomy is an excellent alternative
to other surgical techniques for treating various distal
ureteral pathologies. Advantages include ease and preci-
sion of excision of the ureter and bladder cuff as well as
efficiency in intracorporeal suturing.
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